Thank you, Mr. Chair, and thank you to all the witnesses for their excellent testimony.
Mr. Leslie, I'd like to direct my questions to you, if I may. I know that you have been a champion for raising the particular vulnerabilities of people with Down syndrome, and particularly the need to make sure they're not forgotten in terms of prioritization for vaccination.
I'm wondering if you could expand on the reasons for your call and, in particular, if you have any comments on the federal guidelines on vaccine prioritization and whether you think they should be amended specifically to recommend priority access to people with Down syndrome or other developmental disabilities.